Video Experimental Relacionado
Updated: Sep 9, 2025
11:27
Analysis of SCAP N-glycosylation and Trafficking in Human Cells
Published on: November 8, 2016
8.8K
La supresión de la SREBP por una proteína transmembrana mutada en la cardiomiopatía
Yasushi Takemoto1, Manchir Tserendagva1, Motonari Uesugi2
1Institute for Chemical Research, Kyoto University, Uji, Kyoto, 611-0011, Japan.
The Journal of biological chemistry
|August 30, 2025
Resumen
La proteína TMEM43 suprime la producción de grasa en las células cardíacas mediante la inhibición de los SREBP, un proceso clave en la patogénesis de la miocardiopatía ventricular derecha arritmogénica (CVRA). Este hallazgo revela TMEM43
Área de la Ciencia:
- Genética cardiovascular
- Cardiología molecular
- El metabolismo celular
Sus antecedentes:
- La miocardiopatía ventricular derecha aritmogénica (CARV) implica el reemplazo del tejido adiposo del músculo cardíaco.
- Las mutaciones en TMEM43 están relacionadas con el ARVC, pero su papel en la patogénesis no está claro.
- TMEM43 interactúa con la escvaleno sintasa (SQS) y se localiza en la ER y las membranas nucleares.
Objetivo del estudio:
- Para aclarar el papel preciso de TMEM43 en la patogénesis de ARVC.
- Investigar los mecanismos moleculares por los que TMEM43 influye en la lipogénesis y la diferenciación cardíaca.
Principales métodos:
- Investigó la regulación de TMEM43 de SQS y otras proteínas lipogénicas.
- Se analizó la interacción de TMEM43 con LRPPRC y su efecto sobre las proteínas reguladoras de esteroles (SREBPs).
- Se examinó el impacto de TMEM43 en la actividad transcripcional de SREBP y la localización nuclear.
Principales resultados:
- TMEM43 suprime la expresión de SQS y otras proteínas lipogénicas mediante la inhibición de SREBPs.
- TMEM43 se une a LRPPRC, interrumpiendo su función de coactivador para SREBP.
- TMEM43 secuestra LRPPRC en la membrana nuclear, inhibiendo la actividad de SREBP y la adipogénesis.
Conclusiones:
- TMEM43 es un regulador crítico de la diferenciación de los adipocitos frente a los cardiomiocitos.
- La inhibición de la actividad de SREBP por parte de TMEM43 ofrece una nueva perspectiva sobre la patogénesis del ARVC.
- Comprender el papel de TMEM43 en el metabolismo lipídico es crucial para el desarrollo de terapias ARVC.
Palabras clave:
El proyecto SREBPTMEM43 (en inglés)adipogénesisMiocardiopatíasíntesis de lípidoscoactivador de la transcripciónReglamento de transcripciónMás Videos Relacionados
09:16Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
7.4K
07:34Quantitative Determination of De Novo Fatty Acid Synthesis in Brown Adipose Tissue Using Deuterium Oxide
Published on: May 12, 2023
1.2K
Videos de Conceptos Relacionados
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
27
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
27
01:45Regulation of Nuclear Protein Sorting
2.4K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.4K
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
45
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
45
01:25Cardiomyopathy I: Introduction and Classification
50
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
50
01:31Regulation of the Unfolded Protein Response
2.6K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.6K
01:30Cardiomyopathy II: Dilated Cardiomyopathy
21
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
21